Conjunctiva

Front 1

Common orbital tumor of infancy

Back 1

Capillary hemangioma

Front 2

Symptomatic pinguecula treatment.

Back 2

(1) lubricants
(2) OTC decongestants
(3) mild steroid (lotomax)

Front 3

Congenital tumor from mesoderm and ectoderm; primarily COLLAGEN; located inferior temporal

Back 3

Limbal Dermoid

Front 4

Dermoid in childhood; lipodermoid in adulthood (composed of lipid)

Back 4

Epibulbar choristoma

Front 5

Adenochrome Deposits are caused from

Back 5

(1)epinephrine
(2)propine

Front 6

Flat, superficial, diffuse and may be near limbus or surrounding a penetrating BV; stable; 0 cysts

Back 6

Melanosis

Front 7

Primary aquired melanosis therapeutic options

Back 7

(1) surgery
(2) topical mitomycin C

Front 8

Slate gray within epidermis; seen in Asian populations

Back 8

Scelral Melanocytosis

Front 9

slate gray within epidermis involving eye and skin

Back 9

Nevus of Ota

Front 10

Raise pigmented or nonpigmented; early 50's; 2% of all ocular malig,; fixed to underlying tissue

Back 10

Conjunctival Melanoma

Front 11

High risk factor for blacks to develop choroidal melanoma

Back 11

Nevus of Ota

Front 12

Rare, unilateral premalignant condition. More common in older fair skinned. Nodular, or irregular white lesions (leukoplakia); moveable

Back 12

Conj. Intraepi. Neo.

Front 13

Common white, male 60s. Pink diffuse gelationous and high vascularized. Metasis rare.

Back 13

Conj. Squamous Cell Carcinoma

Front 14

Conj. Squamous Cell Carcinoma present in younger than 50 suspect

Back 14

AIDS

Front 15

Edema and PMN into conj. Central Vessel. response to bacterial and allergies.

Back 15

Papillae

Front 16

Adult with follicles result of:

Back 16

(1) viral
(2) chlamydial
(3) toxic rxn

Front 17

Child with follicles result of:

Back 17

Not a disease; underdeveloped immune system; clear up with age

Front 18

Mucopurulent commonly seen in:

Back 18

(1) bacterial
(2) chylamydial conj.

Front 19

Another name for mucopurulent

Back 19

catarrhal

Front 20

Purulent or hyperacute dischg may be:

Back 20

gonococcal

Front 21

Membrane/Pseudomembrane caused by:

Back 21

(1) adenoviral conj
(2) HSV

Front 22

Common flora of conj.

Back 22

(1) S. epidermis
(2) S. aureus
(3) Corynebacterium

Front 23

Most common cause of primary conj. in immunocompetent childern younger 12

Back 23

bacteria

Front 24

Most common baterial pathogens

Back 24

(1) S. aureus
(2) H. influenza
(3) S. pneumoniae

Front 25

Most common cause of primary conj. in immunocompetent childern over 12 and adults

Back 25

viruses

Front 26

Most common viral pathogens

Back 26

(1) adenovirus
(2) herpes simplex

Front 27

Isolate most ocular aerobic and anaerobic pathogens

Back 27

Blood Agar

Front 28

Blood Agar cannot isolate

Back 28

(1) Haemophilus
(2) Neissera
(3) Moraxella

Front 29

Chocolate Agar isolates

Back 29

(1) Haemophilus
(2) Neissera
(3) Moraxella

Front 30

Sabouraud's Agar isolate

Back 30

Fungi

Front 31

Treatment of Acute Bacterial Conj.

Back 31

(1)Broad spec Antibiotic
(2) Severe inflammation or pseudo/true memb- Steroids

Front 32

Staph Conj. associated with

Back 32

Bleph

Front 33

Diffuse bulbar and palpebral hyperemia, scattered petechial hem, mucopurulent dischg, and marginal corneal infiltrates

Back 33

Pneumococcus Conj. or Haemophilus influenza Conj.

Front 34

Concurrent URTI or otitis media in children younger than 4

Back 34

Pneumococcus Conj.

Front 35

May progress to preseptal or orbital cellulitis

Back 35

Haemophilus influenza Conj.

Front 36

Hyperacute Bacterial Conj. caused by

Back 36

(1) N. gonorrhea
(2) N. meningitis

Front 37

Treatment for Hyperacute Bacterial Conj.

Back 37

(1) systemic and topical therapy
(2) frequent irrigation
(3) hospitalization

Front 38

Untreated Hyperacute Bacterial Conj. can lead to

Back 38

(1) true membrane formation
(2) symblepharon
(3) corneal perforation

Front 39

Chronic Bacterial Conj., commonly seen in clinic, caused by

Back 39

(1) S. aureus
(2) M. lacunata

Front 40

Treatment Chronic Bacterial Conj.

Back 40

(1) lid hygiene
(2) broad spec antibiotic QID flare ups
(3)topical steriod- corneal involve or phlyctenules

Front 41

Conjunctivitis of newborn occuring within the first 4 weeks of life. (normally 3-5 days after delivery)

Back 41

Ophthalmia Neonatorum

Front 42

Ophthalmia Neonatorum- Gonococcal treatment

Back 42

pencillin G

Front 43

Ophthalmia Neonatorum- Chlamydial treatment

Back 43

erythromycin

Front 44

Ophthalmia Neonatorum- S. aureus, H. influenza, S. viridans, P.aeruginosa; treatment

Back 44

erythromycin gram (+)
tobramycin gram (-)

Front 45

Ophthalmia Neonatorum- Herpes simplex treatment

Back 45

trifluorothymidine

Front 46

Ophthalmia Neonatorum- chemical silver nitrate treatment

Back 46

self-limiting

Front 47

Ophthalmia Neonatorum- marked by corneal opacities and possible micropannus

Back 47

Chlamydial

Front 48

Bacitracin

Back 48

inhibits bacterial cell wall synthesis, good gram (+) coverage, poor gram (-)
coverage (except Neisseria

Front 49

changes permeability of the bacterial cell membranes causing cell death,
fair gram (+) coverage, poor gram (-) coverage (except H. influenzae

Back 49

Gramicidin

Front 50

changes permeability of the bacterial cell membranes causing cell death,
no gram (+) coverage, fair gram (-) coverage (good against P. aeruginosa), very important in CL wear, excellent when combined with an effective gram (+) agent.

Back 50

Polymyxin B

Front 51

prevents the conversion of dihydrofolic acid preventing cell growth,
broad spectrum (does not cover P. aeruginosa), excellent choice when combined with Polymyxin B.

Back 51

Trimethoprim

Front 52

inhibits bacterial protein synthesis, ung form used widely, excellent
choice for prophylactic treatment of ophthalmia neonatorum, oral use in C. trachomatis

Back 52

Erythromycin

Front 53

interfere with DNA
synthesis, broad spectrum (99% of pathogens eradicated with 4th gen. FQ’s), very good drugs for initial treatment of bacterial conjunctivitis

Back 53

Fluoroquinolones (nor-, cipro-, o-, moxi-, and gatifloxacin

Front 54

aminoglycoside, inhibits bacterial protein synthesis, broad spectrum, risk of
contact dermatitis limits use

Back 54

Neomycin

Front 55

aminoglycoside, excellent gram (-) coverage, fair gram (+) coverage, can
cause corneal and conj toxicity.

Back 55

Gentamicin

Front 56

aminoglycoside, very similar to gentamicin in efficacy, more potent
against P. aeruginosa, in combo with dexamethasone (Tobradex) is the most widely Rx’ed prescription in the U.S.

Back 56

Tobromycin

Front 57

– inhibits the bacterial synthesis of folic acid, broad spectrum, resistance
and hypersensitivity are common, better options are available

Back 57

Sulfonamides

Front 58

inhibit bacterial protein synthesis, broad spectrum, increasing resistance,
contraindicated in pregnant or nursing women and in children younger than 8.

Back 58

Tetracycline